90 related articles for article (PubMed ID: 4990188)
21. Complete cytogenetic response with host-derived hematopoiesis induced by cyclosporin A discontinuation in a patient with relapsed chronic myelogenous leukemia after bone marrow transplantation.
Suzuki R; Taji H; Iida S; Miura K; Kagami Y; Ogura M; Yatabe Y; Nakamura S; Seto M; Morishima Y
Bone Marrow Transplant; 1997 Oct; 20(7):615-7. PubMed ID: 9337067
[TBL] [Abstract][Full Text] [Related]
22. High dose therapy and autologous bone marrow versus blood cell rescue. South Island Bone Marrow Transplant Unit.
Hill GR; Inder A; Patton WN; Hart DN
N Z Med J; 1996 Feb; 109(1016):45-8. PubMed ID: 8598936
[TBL] [Abstract][Full Text] [Related]
23. [The immunologic reactions and the neoplasms. Trials of immunotherapy].
Mathé G
Acquis Med Recent; 1965; ():113-20. PubMed ID: 5320416
[No Abstract] [Full Text] [Related]
24. Additional myeloablation with 52Fe before bone marrow transplantation.
Jacquy C; Ferrant A; Leners N; Cogneau M; Jamar F; Michaux JL
Bone Marrow Transplant; 1997 Feb; 19(3):191-6. PubMed ID: 9028544
[TBL] [Abstract][Full Text] [Related]
25. Blockade of the CD40/CD154 pathway enhances T-cell-depleted allogeneic bone marrow engraftment under nonmyeloablative and irradiation-free conditioning therapy.
Pan Y; Luo B; Sozen H; Kalscheuer H; Blazar BR; Sutherland DE; Hering BJ; Guo Z
Transplantation; 2003 Jul; 76(1):216-24. PubMed ID: 12865813
[TBL] [Abstract][Full Text] [Related]
26. Allogeneic bone marrow transplantation for children with acute leukemia: cytoreduction with fractionated total body irradiation, high-dose etoposide and cyclophosphamide.
Duerst RE; Horan JT; Liesveld JL; Abboud CN; Zwetsch LM; Senf ES; Constine LS; Raubertas RF; Passarell JA; DiPersio JF
Bone Marrow Transplant; 2000 Mar; 25(5):489-94. PubMed ID: 10713624
[TBL] [Abstract][Full Text] [Related]
27. Allogeneic transplantation for recurrent or refractory non-Hodgkin's lymphoma with poor prognostic features after conditioning with thiotepa, busulfan, and cyclophosphamide: experience in 44 consecutive patients.
van Besien K; Thall P; Korbling M; Pugh WC; Khouri I; Mehra R; Giralt S; Anderlini P; Amin K; Mirza N; Seong D; Gajewski J; Hester J; Andersson B; Cabanillas F; Champlin R; Przepiorka D
Biol Blood Marrow Transplant; 1997 Aug; 3(3):150-6. PubMed ID: 9310192
[TBL] [Abstract][Full Text] [Related]
28. Immunocompetence following autologous bone marrow transplantation.
Gorin NC; Muller JY; Salmon C; Fine JM; Rouger P; Fortier B; Petit JC; Girard O; LeBlanc G; Parlier Y; Najman A; Duhamel G
Exp Hematol; 1979; 7 Suppl 5():327-46. PubMed ID: 400696
[No Abstract] [Full Text] [Related]
29. Tolerance induction in clinical transplantation.
Fehr T; Sykes M
Transpl Immunol; 2004; 13(2):117-30. PubMed ID: 15380542
[TBL] [Abstract][Full Text] [Related]
30. [Current status and the future prospect of bone marrow transplantation in Japan].
Hattori J
Rinsho Ketsueki; 1982 Apr; 23(4):425-32. PubMed ID: 6752477
[No Abstract] [Full Text] [Related]
31. Analysis of prognostic factors for allogeneic marrow transplantation following busulfan and cyclophosphamide in myelodysplastic syndrome and after leukemic transformation.
Copelan EA; Penza SL; Elder PJ; Ezzone SA; Scholl MD; Bechtel TP; Belt PS; Avalos BR
Bone Marrow Transplant; 2000 Jun; 25(12):1219-22. PubMed ID: 10871724
[TBL] [Abstract][Full Text] [Related]
32. High dose chemotherapy with busulfan, cyclophosphamide, and etoposide as conditioning regimen for allogeneic bone marrow transplantation for patients with acute myeloid leukemia in first complete remission.
Zander AR; Berger C; Kröger N; Stockshläder M; Krüger W; Horstmann M; Grimm J; Zeller W; Kabisch H; Erttmann R; Schönrock P; Kuse R; Braumann D; Illiger HJ; Fiedler W; de Witt M; Hossfeld KD; Weh HJ
Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2671-5. PubMed ID: 10068272
[TBL] [Abstract][Full Text] [Related]
33. Effect of extended immunosuppressive drug treatment on B cell vs T cell reconstitution in pediatric bone marrow transplant recipients.
D'Costa S; Slobod KS; Benaim E; Bowman L; Cunningham J; Holladay M; Howlett N; Srivastava DK; Hurwitz JL
Bone Marrow Transplant; 2001 Sep; 28(6):573-80. PubMed ID: 11607770
[TBL] [Abstract][Full Text] [Related]
34. The effect of busulphan on the pharmacokinetics of cyclophosphamide and its 4-hydroxy metabolite: time interval influence on therapeutic efficacy and therapy-related toxicity.
Hassan M; Ljungman P; Ringdén O; Hassan Z; Oberg G; Nilsson C; Békassy A; Bielenstein M; Abdel-Rehim M; Georén S; Astner L
Bone Marrow Transplant; 2000 May; 25(9):915-24. PubMed ID: 10800057
[TBL] [Abstract][Full Text] [Related]
35. Bone marrow transplantation through standard central venous catheters.
Gallardo D; Alonso E; Riu C; Ponce C; Salar A; Ferrà C; Berlanga JJ; Grañena A
Transplant Proc; 1995 Aug; 27(4):2354. PubMed ID: 7652839
[No Abstract] [Full Text] [Related]
36. Orthotopic liver-small bowel transplantation in pigs: study of immunologic parameters during therapy with FK 506-based immunosuppressive regimens.
Perego C; Marelli O; Rossi G; Gatti S; Reggiani P; Orsenigo R; Galmarini D; Franco P
Transplant Proc; 1996 Oct; 28(5):2471-3. PubMed ID: 8907908
[No Abstract] [Full Text] [Related]
37. Effects of ex vivo activated immune cells on syngeneic and semi-allogeneic bone marrow transplantation in mice.
Yang G; Tan J; Wei G; Deng Y; Chen H; Yang D
Transpl Immunol; 2006 Nov; 16(3-4):166-71. PubMed ID: 17138049
[TBL] [Abstract][Full Text] [Related]
38. High-dose chemotherapy combined with escalating doses of cyclosporin A and an autologous bone marrow transplant for the treatment of drug-resistant solid tumors: a phase I clinical trial.
Stiff PJ; Bayer R; Tan S; Camarda M; Sosman J; Peace D; Kinch L; Rad N; Loutfi S
Clin Cancer Res; 1995 Dec; 1(12):1495-502. PubMed ID: 9815949
[TBL] [Abstract][Full Text] [Related]
39. Correction of bone marrow failure in dyskeratosis congenita by bone marrow transplantation.
Ghavamzadeh A; Alimoghadam K; Nasseri P; Jahani M; Khodabandeh A; Ghahremani G
Bone Marrow Transplant; 1999 Feb; 23(3):299-301. PubMed ID: 10084264
[TBL] [Abstract][Full Text] [Related]
40. Bone marrow transplantation in thalassemia major patients using "short" anti-thymocyte globulin therapy in Shiraz, Southern Iran.
Zakerinia M; Khojasteh HN; Ramzi M; Haghshenas M
Transplant Proc; 2005 Dec; 37(10):4477-81. PubMed ID: 16387149
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
